| Primary |
| Non-small Cell Lung Cancer |
29.9% |
| Drug Use For Unknown Indication |
16.1% |
| Hepatocellular Carcinoma |
10.9% |
| Pancreatic Carcinoma |
6.3% |
| Lung Neoplasm Malignant |
5.4% |
| Product Used For Unknown Indication |
5.2% |
| Pancreatic Carcinoma Metastatic |
3.4% |
| Nasopharyngeal Cancer |
3.1% |
| Non-small Cell Lung Cancer Stage Iv |
3.1% |
| Lung Adenocarcinoma |
2.3% |
| Colon Cancer |
1.9% |
| Colorectal Cancer Metastatic |
1.9% |
| Head And Neck Cancer |
1.7% |
| Neoplasm Malignant |
1.5% |
| Premedication |
1.5% |
| Rectal Cancer |
1.3% |
| Bronchial Carcinoma |
1.1% |
| Lung Cancer Metastatic |
1.1% |
| Pain |
1.1% |
| Adenocarcinoma Pancreas |
1.0% |
|
| Vomiting |
12.1% |
| Pneumonia |
8.1% |
| White Blood Cell Count Decreased |
8.1% |
| Death |
7.1% |
| Renal Failure Acute |
7.1% |
| Rash |
6.1% |
| Weight Decreased |
6.1% |
| Disease Progression |
5.1% |
| Pulmonary Embolism |
5.1% |
| Pyrexia |
5.1% |
| Unresponsive To Stimuli |
5.1% |
| General Physical Health Deterioration |
3.0% |
| Hypertension |
3.0% |
| Metastases To Central Nervous System |
3.0% |
| Nausea |
3.0% |
| Pancreatic Carcinoma Metastatic |
3.0% |
| Rectal Haemorrhage |
3.0% |
| Sudden Death |
3.0% |
| Cardiac Arrest |
2.0% |
| Diarrhoea |
2.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
29.7% |
| Hepatocellular Carcinoma |
24.4% |
| Non-small Cell Lung Cancer |
13.4% |
| Oesophageal Carcinoma |
4.8% |
| Pancreatic Carcinoma |
4.4% |
| Hepatic Neoplasm Malignant |
3.0% |
| Pancreatic Carcinoma Metastatic |
2.7% |
| Hypertension |
2.5% |
| Pain |
2.2% |
| Product Used For Unknown Indication |
1.9% |
| Nausea |
1.4% |
| Glioblastoma |
1.3% |
| Colorectal Cancer Metastatic |
1.2% |
| Lung Neoplasm Malignant |
1.2% |
| Head And Neck Cancer |
1.1% |
| Renal Cell Carcinoma |
1.1% |
| Neoplasm Malignant |
1.0% |
| Glioblastoma Multiforme |
0.9% |
| Rash |
0.9% |
| Diarrhoea |
0.9% |
|
| Vomiting |
18.5% |
| Pyrexia |
12.7% |
| Death |
10.9% |
| Hypokalaemia |
7.1% |
| Pneumonia |
6.1% |
| Rash |
6.1% |
| Oesophagitis |
5.1% |
| Respiratory Failure |
3.9% |
| Mucosal Inflammation |
3.4% |
| Thrombocytopenia |
3.4% |
| Oedema Peripheral |
2.9% |
| Dyspnoea |
2.4% |
| Sepsis |
2.4% |
| Sudden Death |
2.4% |
| Diarrhoea |
2.2% |
| Pneumonia Aspiration |
2.2% |
| Renal Failure Acute |
2.2% |
| Wheezing |
2.2% |
| Intestinal Obstruction |
1.9% |
| Skin Ulcer |
1.9% |
|
| Concomitant |
| Non-small Cell Lung Cancer |
30.8% |
| Drug Use For Unknown Indication |
15.5% |
| Lung Neoplasm Malignant |
5.8% |
| Pancreatic Carcinoma |
5.8% |
| Pain |
5.2% |
| Product Used For Unknown Indication |
3.7% |
| Prophylaxis |
3.7% |
| Cardiomyopathy |
3.0% |
| Bronchial Carcinoma |
2.7% |
| Nausea |
2.7% |
| Neoplasm Malignant |
2.7% |
| Non-small Cell Lung Cancer Metastatic |
2.7% |
| Metastases To Bone |
2.1% |
| Pancreatic Carcinoma Metastatic |
2.1% |
| Pancreatic Carcinoma Stage Iv |
2.1% |
| Appetite Disorder |
1.8% |
| Breast Cancer Metastatic |
1.8% |
| Cardiovascular Disorder |
1.8% |
| Colorectal Cancer Metastatic |
1.8% |
| Dyspnoea |
1.8% |
|
| Vomiting |
13.6% |
| Renal Failure |
8.6% |
| Acute Respiratory Failure |
6.2% |
| Pneumonia |
6.2% |
| Thrombocytopenia |
6.2% |
| Weight Bearing Difficulty |
6.2% |
| Cardiac Death |
4.9% |
| Death |
4.9% |
| Renal Failure Acute |
4.9% |
| Respiratory Failure |
4.9% |
| Sepsis |
4.9% |
| Tachycardia |
4.9% |
| Drug Ineffective |
3.7% |
| Nausea |
3.7% |
| Pulmonary Embolism |
3.7% |
| Dehydration |
2.5% |
| Dry Mouth |
2.5% |
| Dysphagia |
2.5% |
| Dyspnoea |
2.5% |
| Febrile Neutropenia |
2.5% |
|
| Interacting |
| Lung Adenocarcinoma |
38.5% |
| Adenocarcinoma Pancreas |
23.1% |
| Drug Use For Unknown Indication |
15.4% |
| Hypertension |
7.7% |
| Liver Transplant |
7.7% |
| Non-small Cell Lung Cancer |
7.7% |
|
| Hepatitis |
25.0% |
| Paralysis |
25.0% |
| Respiratory Tract Infection |
25.0% |
| Skin Toxicity |
25.0% |
|
